Overall Status

Terminated (2)

Completed (1)

Enrolling by invitation (1)

Phase

phase 2 (2)

Sponsor

Aristotle University Of Thessaloniki (1)

Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori (1)

St Vincent's Hospital, Sydney (1)

University of California, Irvine (1)

Collaborator

Applied Biology, Inc. (1)

Intervention

covid-19 androgen sensitivity test (covast) (1)

dhea (1)

real time pcr (1)

sevi-d (seviteronel in combination with dexamthasone) (1)

Study Documents

Intervention Type

drug (2)

genetic (2)

Funder Type

Other (4)

Study Type

Interventional (2)

Observational (1)

Observational [Patient Registry] (1)

androgen receptor gene overexpression

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Solid Tumor, Androgen Receptor Gene Overexpression Trial in Darlinghurst (SEVI-D (Seviteronel in combination with dexamthasone))

Terminated

Solid Tumor
Androgen Receptor Gene Overexpression

SEVI-D (Seviteronel in combination with dexamthasone)

Darlinghurst, New South Wales, Australia

St Vincent's Hospital

Mar 2, 2021

COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene

Enrolling by invitation

Covid19
Androgen Receptor Gene Overexpression

COVID-19 Androgen Sensitivity Test (CoVAST)

Irvine, California
+1 more

Dec 9, 2020

Androgen Receptor Gene Overexpression, Normal Responders, Poor Ovarian Response Trial (Real time PCR)

Completed

Androgen Receptor Gene Overexpression
+3 more

Real time PCR

(no location specified)

Feb 8, 2018

Metastatic Breastcancer, Estrogen Receptor Positive Breast Cancer, Estrogen Receptor Negative Tumor Trial in Italy (DHEA)

Terminated

Metastatic Breastcancer
+5 more

DHEA

Meldola, FC, Italy
+7 more

Sep 28, 2016